Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of Clinical Hepatology ; (12): 1191-1195, 2024.
Article in Chinese | WPRIM | ID: wpr-1032269

ABSTRACT

ObjectiveTo investigate the efficacy and safety of artificial liver support therapy with an Evanure-4A selective membrane plasma separator and its influence on platelet count in the treatment of patients with acute-on-chronic liver failure (ACLF) patients with different platelet counts. MethodsA total of 302 patients with ACLF who were hospitalized in Department of Hepatology, Chengdu Public Health Clinical Medical Center, from January 2021 to May 2023, were enrolled, and according to the platelet count (PLT), they were divided into group A (25×109/L — 50×109/L) with 101 patients, group B (51×109/L — 80×109/L) with 98 patients, and group C (81×109/L — 100×109/L) with 103 patients. In addition to medical treatment, all patients received different modes of artificial liver support therapy based on their conditions, including plasma perfusion combined with plasma exchange, double plasma molecular adsorption combined with plasma exchange, and bilirubin system adsorption combined with plasma exchange. The paired t-test was used for comparison of continuous data before and after treatment in each group; an analysis of variance was used for comparison between multiple groups, and the SNK-q test was used for further comparison between two groups; the chi-square test was used for comparison of categorical data between multiple groups. ResultsOf all 302 patients, 268 (88.74%) achieved varying degrees of improvement in clinical symptoms after artificial liver support therapy. After treatment, all three groups had varying degrees of reductions in alanine aminotransferase (t=14.755, 21.614, and 15.965, all P<0.001), aspartate aminotransferase (t=11.491, 19.301, and 13.919, all P<0.001), total bilirubin (t=19.182, 17.486, and 21.75, all P<0.001), and international normalized ratio (INR) (t=3.497, 3.327, and 4.358, all P<0.05). After artificial liver support therapy with an Evanure-4A selective membrane plasma separator, PLT in group A decreased from (37.73±6.27)×109/L before treatment to (36.59±7.96)×109/L after treatment, PLT in group B decreased from (66.97±7.64)×109/L before treatment to (62.59±7.37)×109/L after treatment, and PLT in group C decreased from (93.82±5.38)×109/L before treatment to (85.99±12.49)×109/L after treatment; groups B and C had significant reductions in PLT after treatment (t=12.993 and 8.240, both P<0.001), but there was no significant difference in group A (P>0.05). There was no significant difference in the incidence rate of adverse reactions during artificial liver support therapy between the three groups (P>0.05). ConclusionArtificial liver support therapy can improve liver function and INR in patients with ACLF. The use of Evaure-4A selective membrane plasma separator during artificial liver support therapy has little influence on platelets, and it is safe in the treatment of ACLF patients with a significantly lower level of platelets.

2.
Article in Chinese | WPRIM | ID: wpr-876066

ABSTRACT

@#Objective    To analyze the clinical features and prognosis of coronavirus disease 2019 (COVID-19) patients. Methods    A total of 379 confirmed COVID-19 patients admitted to Public Health Clinical Center of Chengdu from January 16 to November 30, 2020 were divided into two groups including an elderly group (42 patients, ≥60 years) and a non-elderly group (337 patients, <60 years) by age. The epidemiology, clinical features, laboratory tests, treatment and prognosis of the two groups were compared. Results    Among the 379 patients, 286 (75.5%) were males and 93 (24.5%) were females, aged from 2 months to 87 years, with an average age of 41.2 years. The average age of the elderly group was 69.5 years, and 61.9% of them were females. They were imported from Wuhan or local secondary patients (73.8%), mainly common or critical type (88.1%). While, the average age of the non-elderly group was 37.8 years, and males were more common (80.1%). There were mostly from foreign input (75.7%), mainly mild or ordinary type (95.0%). A total of 179 patients (47.2%) had one or more underlying diseases. Hypertension (15 patients, 35.7%) and diabetes (11 patients, 26.2%) were more common in the elderly group, while non-alcoholic steatohepatitis (132 patients, 39.2%) was more frequent in the non-elderly group. The most common clinical manifestations were fever (138 patients, 36.4%) and cough (129 patients, 34.0%). Fever, cough, dyspnea, and fatigue were more common in the elderly group than those in the non-elderly group (P<0.05). Compared with the non-elderly group, the elderly group had lower total lymphocyte count, CD4+ and CD8+ T-cell count, higher level of myocardial injury or inflammation markers (P<0.05). Abnormal echocardiography in 139 patients (36.7%) was mainly caused by decreased left ventricular diastolic function (22.7%) and heart valve regurgitation (14.0%), and the rate in the elderly group was significantly higher than that in the non-elderly group (85.7% vs. 30.6%, P<0.05). After treatment, 3 patients in the elderly group died, and the others were cured and discharged. The hospitalization duration of the elderly group was longer than that of the non-elderly group (22.1 d vs. 18.8 d, P=0.033). Conclusions    Elderly COVID-19 patients are mainly imported from Wuhan or secondary to the local population, mainly common or critical type, often associated with basic diseases such as hypertension or diabetes. While, non-elderly COVID-19 patients are mainly imported from abroad, mainly mild or common type, often associated with non-alcoholic steatohepatitis. After treatment, most of the patients have a good prognosis.

3.
Article in Chinese | WPRIM | ID: wpr-589944

ABSTRACT

Objective To observe the efficiency of radiofrequency ablation on inferior nasal concha hypertrophy under nasal endoscope.Methods The radiofrequency ablation needle was applied to inferior nasal concha under 0? nasal endoscope.Results Nasal obstruction was evidently improved,the volume of inferior nasal concha became normal,and the surface became smooth 4 weeks after operation.Efficiency was assessed according to nasal obstruction visual analogue scale(VAS),in which the scale was significantly reduced from(7.9?1.0)points preoperatively to(4.1?0.9)points at 6 months postoperatively(t=2.316,P=0.027).Conclusions Radiofrequency ablation is an effective alternative to treat inferior nasal concha hypertrophy under nasal endoscope.

SELECTION OF CITATIONS
SEARCH DETAIL